For Vertex these days, it’s all about the launches of three new products—sickle cell disease gene therapy Casgevy, the ...

In a report released today, Mariana Perez Mora from Bank of America Securities reiterated a Hold rating on V2X (VVX – Research Report), with a ...

By Rick Winterson  Vertex Pharmaceuticals is a worldwide biotechnology corporation. It was founded 35 years ago in Cambridge.  It has now established its global headquarters on Fan Pier in South ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

To get it in your inbox, sign up for free here. New York CNN — This is how much Corporate America loves lower taxes: There’s a guy holding a knife to the neck of the federal institutions that ...

After hours: February 7 at 7:31:24 PM EST Loading Chart for VERX ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vehicle to everything: V2X is an umbrella term that encompasses all bidirectional charging options. While bidirectional functionality is by no means universal, automakers are swiftly adding it to ...

Copyright 2025 The Associated Press. All Rights Reserved. The Trump administration said Tuesday that it is pulling almost all USAID workers off the job and out of the ...